• Profile
Close

Long-term clinical outcomes of catheter ablation in patients with atrial fibrillation predisposing to tachycardia-bradycardia syndrome: A long pause predicts implantation of a permanent pacemaker

BMC Cardiovascular Disorders Jun 07, 2018

Kim DH, et al. - Researchers investigated if catheter ablation should be first-line therapy for tachycardia-bradycardia syndrome (TBS) in patients with atrial fibrillation (AF). They analyzed the long-term clinical outcomes of catheter ablation in patients with TBS and AF. They noted that, during a mean 21 months after ablation, a permanent pacemaker was implanted in 11 of 121 patients. Relative to patients who underwent ablation only, a significantly greater length of pause on termination of AF was noted in those who received pacemaker implantation after ablation. Following catheter ablation, the need to implant a permanent pacemaker was predicted by long pause on termination of AF in patients with AF predisposing to TBS.

Full text available Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay